Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza Season - Top-Institutions - MDSpire

Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza Season

  • By

  • Hannah Bahakel

  • Andrew J Spieker

  • Haya Hayek

  • Jennifer E Schuster

  • Lubna Hamdan

  • Daniel E Dulek

  • Carrie L Kitko

  • Tess Stopczynski

  • Einas Batarseh

  • Zaid Haddadin

  • Laura S Stewart

  • Anna Stahl

  • Molly Potter

  • Herdi Rahman

  • Justin Amarin

  • Spyros A Kalams

  • Claire E Bocchini

  • Elizabeth A Moulton

  • Susan E Coffin

  • Monica I Ardura

  • Rachel L Wattier

  • Gabriela Maron

  • Michael Grimley

  • Grant Paulsen

  • Christopher J Harrison

  • Jason Freedman

  • Paul A Carpenter

  • Janet A Englund

  • Flor M Munoz

  • Lara Danziger-Isakov

  • Natasha Halasa

  • for the Pediatric HCT Flu Study

  • Rakesh Goyal

  • Rendie McHenry

  • Margaret Bender

  • Shari Barto

  • Michael Russo

  • Lauren Shoemaker

  • Kenny Truong

  • Christopher Dvorak

  • Kim J Allison

  • Swati Naik

  • Christopher Williams

  • Samantha Blum

  • Kirsten Lacombe

  • Hannah Smith

  • September 16, 2024

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematopoietic Cell Transplantation
    • Pediatric Oncology
    • Infectious Diseases

  • #2

    St. Jude Children's Research Hospital
    St. Jude Children's Research Hospital

    Memphis, TN

    Key Differentiators

    • Pediatric Hematology/Oncology
    • Immunology
    • Infectious Diseases

  • #3

    Children's Hospital of Philadelphia (CHOP)
    Children's Hospital of Philadelphia (CHOP)

    Philadelphia, PA

    Key Differentiators

    • Pediatric Hematology/Oncology
    • Transplantation
    • Infectious Diseases

  • #4

    Dana-Farber/Boston Children's Cancer and Blood Disorders Center
    Dana-Farber/Boston Children's Cancer and Blood Disorders Center

    Boston, MA

    Key Differentiators

    • Pediatric Hematology/Oncology
    • Stem Cell Transplantation
    • Immunology

  • #5

    National Institutes of Health (NIH) - National Cancer Institute
    National Institutes of Health (NIH) - National Cancer Institute

    Bethesda, MD

    Key Differentiators

    • Hematopoietic Cell Transplantation
    • Immunology
    • Infectious Diseases

Original Source(s)

Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza Season

  • by Hannah Bahakel, Andrew J Spieker, Haya Hayek, Jennifer E Schuster, Lubna Hamdan, Daniel E Dulek, Carrie L Kitko, Tess Stopczynski, Einas Batarseh, Zaid Haddadin, Laura S Stewart, Anna Stahl, Molly Potter, Herdi Rahman, Justin Amarin, Spyros A Kalams, Claire E Bocchini, Elizabeth A Moulton, Susan E Coffin, Monica I Ardura, Rachel L Wattier, Gabriela Maron, Michael Grimley, Grant Paulsen, Christopher J Harrison, Jason Freedman, Paul A Carpenter, Janet A Englund, Flor M Munoz, Lara Danziger-Isakov, Natasha Halasa, for the Pediatric HCT Flu Study, Rakesh Goyal, Rendie McHenry, Margaret Bender, Shari Barto, Michael Russo, Lauren Shoemaker, Kenny Truong, Christopher Dvorak, Kim J Allison, Swati Naik, Christopher Williams, Samantha Blum, Kirsten Lacombe, Hannah Smith

  • September 16, 2024

Related Content

Self-administered digital vaccination decision-aids in primary care: A pilot study of COVID-19 vaccination in Atlanta, GA

Assessing PEPFAR’s Health Spillover Effects Beyond HIV: An Update

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications